TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 1nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 2nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 2nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 2nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 2nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 2nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 2nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 2nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 3nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 4nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 4nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 4nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 5nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 6nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 6nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 7nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 8nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 8nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 11nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 14nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
TargetNon-receptor tyrosine-protein kinase TYK2 [556-871](Homo sapiens (Human))
JANSSEN PHARMACEUTICA NV
WIPO
JANSSEN PHARMACEUTICA NV
WIPO
Affinity DataIC50: 42nMAssay Description:The probe displacement assay is conducted as follows: In a 384-well plate, test compound along with recombinantly expressed His-tagged protein corres...More data for this Ligand-Target Pair
